肛门生殖器基底细胞癌的基因组与临床特征:回顾性与前瞻性队列研究
该研究纳入2006至2024年诊断的50例肛门生殖器基底细胞癌患者(40例女性,10例男性),评估临床病理特征并对12例进行全基因组或全外显子测序。结果显示结节型和浸润型为主, vulva(外阴)在女性中最常受累,肛周在男性中占优;基因组分析示肿瘤突变负荷低(3.4 mutations/Mb),无紫外线突变特征,PTCH1突变频繁(75%), sonic hedgehog通路激活。结论认为该亚型具有独特特征,需调整诊疗策略。
要点
- 肛门生殖器基底细胞癌好发于女性外阴和男性肛周,结节型与浸润型常见。
- 治疗以手术切除为主,复发率15%,中位随访7年。
- 基因组特征为低肿瘤突变负荷、无紫外线特征、PTCH1突变及sonic hedgehog通路激活。
核心结论
- 肛门生殖器基底细胞癌具有独特的临床病理和基因组特征,包括较高的复发率、紫外线非依赖性和sonic hedgehog通路激活,需要适配的诊断和治疗策略。
研究设计与样本
- 全国性回顾性-前瞻性队列研究,纳入2006至2024年诊断的50例肛门生殖器基底细胞癌患者(40例女性,10例男性),对12例进行全基因组或全外显子测序。
主要发现
- 女性中最常受累部位为外阴,男性中为肛周;3例有既往盆腔放疗史。
- 结节型(n=23,46%)和浸润型(n=22,45%)为主,18%的外阴基底细胞癌发生于硬化性苔藓。
- 大多数病例(n=42,84%)仅接受手术切除,3例(6%)接受新辅助hedgehog抑制剂治疗。
- 治疗后复发率为15%(中位随访7年)。
- 基因组分析(n=12)显示肿瘤突变负荷低(3.4 mutations/Mb),无紫外线突变特征,PTCH1突变频繁(75%),sonic hedgehog通路激活。
关键数值与推荐
- 复发率15%(中位随访7年)。
- 肿瘤突变负荷3.4 mutations/Mb(n=12)。
- PTCH1突变频率75%(n=12)。
临床怎么用
- 临床应认识到肛门生殖器基底细胞癌的独特特征,包括较高复发风险,需个体化随访。
- 基因组特征提示紫外线非依赖和sonic hedgehog通路激活,可考虑相关靶向治疗。
局限性
- 样本量小且为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anogenital basal cell carcinoma (BCC) is a rare and poorly understood subtype occurring in sun-protected areas. OBJECTIVE: To investigate the clinicopathological and genomic characteristics of anogenital BCC. METHODS: Patients with anogenital BCC diagnosed between 2006 and 2024 were included from a nationwide retrospective-prospective cohort. Clinicopathological features were assessed, and whole-genome or whole-exome sequencing was performed for genomic analysis. RESULTS: Among 50 patients (40 female, 10 male), the vulva was the most frequently affected site in women, whereas the perianal region prevailed in men. 3 patients had prior pelvic radiotherapy. Nodular (n = 23, 46%) and infiltrative subtypes (n = 22, 45%) predominated, with 18% of vulvar BCCs developing on lichen sclerosus. Most cases (n = 42, 84%) underwent surgical removal alone; 3 (6%) received neoadjuvant hedgehog inhibitors. Recurrence occurred in 15% of treated cases (median follow-up: 7 years). Genomic analyses (n = 12) revealed low tumor mutational burden (3.4 mutations/Mb), no UV mutational signatures, frequent PTCH1 mutations (75%), and activation of the sonic hedgehog pathway. LIMITATIONS: Small sample size and retrospective design. CONCLUSION: Anogenital BCCs exhibit distinct clinicopathological and genomic features, including higher recurrence rates, UV-independence, and sonic hedgehog pathway activation, requiring adapted diagnostic and treatment strategies.
引用
- Dousset L, Yurchenko AA, Chanal J, et al. Genomic and clinical characterization of anogenital basal cell carcinoma: A retrospective and prospective cohort study. J Am Acad Dermatol. 2025. PMID: 40854498. doi:10.1016/j.jaad.2025.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。